抗核抗体谱与结缔组织疾病相关间质性肺病的研究进展
Research Progress of Antinuclear Antibody Profile and Connective Tissue Dis-ease-Related Interstitial Lung Disease
DOI: 10.12677/ACM.2023.13102349, PDF,   
作者: 王 娟*：新疆医科大学第一临床医学院，新疆 乌鲁木齐；刘 晖#：新疆医科大学第一附属医院呼吸三科，新疆 乌鲁木齐
关键词: 抗体；结缔组织疾病相关间质性肺病；肺间质损害；Antinuclear Antibody Profile； Connective Tissue Disease-Related Interstitial Lung Disease； Intersti-tial Lung Damage
摘要: 本文主要介绍了抗核抗体谱与CTD-ILD的研究现状和未来展望。近年来，CTD-ILD在人群中的患病率较以往有所上升，严重影响了CTD患者的生活质量，往往预后不良，甚至危及生命。本文就患者抗核抗体谱与CTD-ILD之间的联系做一探讨及总结，包括各种CTD与抗核抗体谱以及抗核抗体谱与结缔组织疾病相关间质性肺病的关系进行梳理，整理出危险因素，进而肺间质损害进行早期筛查和干预，极大可能可以改善SLE-ILD患者的预后。
Abstract: This article mainly introduces the research status and future prospects of antinuclear antibody pro-file and CTD-ILD. In recent years, the prevalence of CTD-ILD in the population has increased com-pared with the past, which has seriously affected the quality of life of CTD patients, often with poor prognosis and even life-threatening. This article discusses and summarizes the relationship be-tween antinuclear antibody profile and CTD-ILD in patients, including the relationship between various CTDs and antinuclear antibody profile, and antinuclear antibody profile and connective tis-sue disease-related interstitial lung disease, and sorts out the risk factors, and then conducts early screening and intervention of lung interstitial damage, which is likely to improve the prognosis of patients with SLE-ILD.
文章引用：王娟, 刘晖. 抗核抗体谱与结缔组织疾病相关间质性肺病的研究进展[J]. 临床医学进展, 2023, 13(10): 16779-16785. https://doi.org/10.12677/ACM.2023.13102349

参考文献

[1] Hernandez-Gonzalez, F., Prieto-González, S., Brito-Zeron, P., Cuerpo, S., Sanchez, M., Ramirez, J., et al. (2020) Impact of a Systematic Evaluation of Connective Tissue Disease on Diagnosis Approach in Patients with Interstitial Lung Dis-eases. Medicine, 99, e18589. [Google Scholar] [CrossRef] 
[2] Jee Adelle, S. and Corte Tam-era, J. (2019) Current and Emerging Drug Therapies for Connective Tissue Disease-Interstitial Lung Disease (CTD-ILD). Drugs, 79, 1511-1528. [Google Scholar] [CrossRef] [PubMed]
[3] 庞宇洁, 张莉芸, 许珂. 血清KL-6在结缔组织病相关间质性肺疾病中的临床应用价值研究[J]. 中国药物与临床, 2018, 18(S1): 16-18.
[4] Tezcan, D., Sivrikava, A., Ergun, D., et al. (2021) Evaluation of Serum Interleukin-6 (IL-6), IL-13, and IL-17 Levels and Computed Tomography Finding in Interstitial Lung Disease Associated with Connective Tissue Dis-ease Patients. Clinical Rheumatology, 40, 4713-4724. [Google Scholar] [CrossRef] [PubMed]
[5] 王宏伟. 抗核抗体谱检测对弥漫性结缔组织病的临床诊断价值分析[J]. 临床医药文献电子杂志, 2017, 4(7): 1313.
[6] Toyoda, Y., Koyama, K., Kawano, H., et al. (2019) Clinical Features of Interstitial Pneumonia Associated with Systemic Lupus Erythematosus. Respiratory Investigation, 57, 435-443. [Google Scholar] [CrossRef] [PubMed]
[7] 崔晓蕊. 系统性红斑狼疮合并间质性肺炎的临床分析[D]: [硕士学位论文]. 长春: 吉林大学, 2019.
[8] 黄卫东, 虞丽诗, 张春宏. 结缔组织病相关间质性肺病患者肌炎自身抗体阳性的临床特征及其与特发性炎性肌病的关系研究[J]. 现代实用医学, 2022, 34(11): 1421-1423.
[9] 王楠, 刘红菊. 抗MDA5-DM合并快速进展性间质性肺病的预后预测因素研究进展[J]. 中国医药导报, 2023, 20(16): 50-53+79.
[10] Chen, F., et al. (2023) Clinical Characteristics of Dermatomyositis Patients with Isolated Anti-Ro-52 Antibody Associated Rapid Progressive Interstitial Lung Disease: Data from the Largest Single Chinese Center. Respir-atory Medicine, 155, 127-132. [Google Scholar] [CrossRef] [PubMed]
[11] 徐紫荆, 周冬梅, 殷松楼, 殷寒秋. NLR、FAR及自身抗体检测在系统性红斑狼疮合并间质性肺病中的预测价值[J]. 医学研究杂志, 2022, 51(7): 153-157.
[12] Adelle, S.J., Stephen, A., Jane, B., et al. (2017) Role of Autoantibodies in the Diagnosis of Connec-tive-Tissue Disease ILD (CTD-ILD) and Interstitial Pneumonia with Autoimmune Features (IPAF). Journal of Clinical Medicine, 6, Article No. 51. [Google Scholar] [CrossRef] [PubMed]
[13] Hyldgaard, C., Hilberg, O., Pedersen, A.B., et al. (2017) A Population-Based Cohort Study of Rheumatoid Arthritis-Associated Interstitial Lung Disease: Comorbid-ity and Mortality. Annals of the Rheumatic Diseases, 76, 1700-1706. [Google Scholar] [CrossRef] [PubMed]
[14] 梁金, 殷寒秋, 殷松楼. 抗CCP抗体、抗MCV抗体联合检测在类风湿关节炎合并间质性肺病中的意义[J]. 医学研究杂志, 2022, 51(1): 120-124.
[15] 张利军. 血清抗CCP抗体、GPI、HLA-DR4联合检测对类风湿关节炎的诊断价值[J]. 检验医学与临床, 2019, 16(6): 814-816.
[16] 吴少麟, 廖燕飞, 夏汝年, 等. RF、抗CCP抗体对类风湿关节炎患者并发心血管疾病的影响分析[J]. 系统医学, 2022, 7(4): 21-25.
[17] Roos, L.K., Joshua, V., Skogh, T., Eklund, A., et al. (2020) Secretory An-ti-Citrullinated Protein Antibodies in Serum Associate with Lung Involvement in Early Rheumatoid Arthritis. Rheuma-tology (Oxford, England), 59, 852-859. [Google Scholar] [CrossRef] [PubMed]
[18] 王琼. 系统性硬化症合并间质性肺病的临床分析[D]: [硕士学位论文]. 郑州: 郑州大学, 2019.
[19] Nihtyanova, S.I., Schreiber, B.E., Ong, V.H., et al. (2014) Prediction of Pulmonary Complications and Long-Term Survival in Systemic Sclerosis. Arthritis & Rheumatology, 66, 1625-1635. [Google Scholar] [CrossRef] [PubMed]
[20] 王迁, 徐东, 李梦涛, 侯勇, 白伊娜, 胡朝军, 宋宁, 赵久良, 张奉春, 赵岩, 曾小峰. 硬皮病相关自身抗体谱与中国系统性硬化患者临床相关性分析[J]. 北京医学, 2010, 32(7): 499-503. [Google Scholar] [CrossRef] 
[21] Heus, A., Arends, S., Van Nimwegen, J.F., et al. (2020) Pulmonary Involvement in Primary Sjӧgren’s Syndrome, as Measured by the ESSDAI. The Scandinavian Journal of Rheumatology, 49, 38-46. [Google Scholar] [CrossRef] [PubMed]
[22] Zhang, T., Yuan, F., Xu, L., et al. (2020) Characteristics of Patients with Primary Sjögren’s Syndrome Associated Interstitial Lung Disease and Relevant Features of Disease Pro-gression. Rheumatology, 39, 1561-1568. [Google Scholar] [CrossRef] [PubMed]
[23] 陈嘉琪, 张丽宁, 杨建英, 黄子玮, 胡琪, 罗静, 陶庆文. 原发性干燥综合征不同抗体阳性患者免疫炎症与疾病活动度特点[J]. 中国免疫学杂志, 2022, 38(11): 1379-1382.
[24] Mofors, J., Bjork, A., Smedby, K.E., et al. (2020) Increased Risk of Multiple Myeloma in Primary Sjӧgren’s Syndrome Is Limited to Individuals with Ro/SSA and La/SSB Autoantibodies. Annals of the Rheumatic Dis-eases, 79, 307-308. [Google Scholar] [CrossRef] [PubMed]
[25] 冯秀南, 陈露, 龙钰, 姜振宇, 赵令. 干燥综合征并发间质性肺病患者临床特征及其危险因素分析[J]. 吉林大学学报(医学版), 2023: 1-6.
[26] Temmoku, J., Sato, S., Fujita, Y., et al. (2019) Clinical Significance of Myositis-Specific Autoantibody Profiles in Japanese Patients with Poly-myositis/Dermatomyositis. Medicine (Baltimore), 98, e15578. [Google Scholar] [CrossRef] 

为你推荐